RxDoctor Payments DataLook up a doctor →

Michele Raymond, DO

Family Medicine · Port Huron, MINPI 1689641557

Payments from drug & device makers

$23,513in general payments, 2019–2025

Across 1,444 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$2K
  • Pfizer$1K
  • Amgen$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca115$2,973
AbbVie(2 entities)192$2,485
Novo Nordisk166$2,237
Lilly USA, LLC126$1,578
Pfizer86$1,422
Amgen76$1,386
GSK90$1,082
Teva Pharmaceuticals USA, Inc.46$881
Merck49$783
Boehringer Ingelheim43$763
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)55$731
Bayer37$591
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC35$573
Vanda Pharmaceuticals Inc.25$533
Otsuka America Pharmaceutical, Inc.26$412
Johnson & Johnson20$407
Takeda Pharmaceuticals U.S.A., Inc.23$348
Sanofi-aventis U.S. LLC19$347
Mylan Specialty L.p.19$330
Alkermes, Inc.15$301
Axsome Therapeutics, Inc.18$291
Idorsia Pharmaceuticals US Inc12$234
Abbott11$222
Amarin Pharma, Inc.13$222
Lundbeck LLC9$212
Biohaven Pharmaceuticals, Inc.5$204
E.r. Squibb & Sons, L.L.C.14$197
Astellas Pharma US Inc10$163
Eisai Inc.7$129
Paratek Pharmaceuticals, Inc.7$119
Exact Sciences6$109
Novartis5$103
Sumitomo Pharma America, Inc.5$102
Corcept Therapeutics4$82
Grifols USA, LLC4$82
Upsher-smith Laboratories LLC4$75
Viatris Specialty LLC4$74
Currax Pharmaceuticals LLC5$74
Biohaven Pharmaceutical Holding Company Ltd.3$65
Xeris Pharmaceuticals, Inc.3$53
UCB, Inc.3$48
Alnylam Pharmaceuticals Inc.2$41
Biodelivery Sciences International, Inc.3$41
Jazz Pharmaceuticals Inc.2$40
Neurocrine Biosciences, Inc.2$34
Circassia Inc.2$32
Phathom Pharmaceuticals, Inc.2$30
Alvogen Inc2$29
Kowa Pharmaceuticals America, Inc.2$27
Vivus LLC1$23
Dexcom, Inc.1$20
Inari Medical, Inc.1$20
Adlon Therapeutics L.p.1$19
Seqirus USA Inc1$19
Tris Pharma Inc1$18
Esperion Therapeutics, Inc.1$18
Biogen1$17
Radius Health, Inc.1$16
Avanir Pharmaceuticals, Inc.1$16
Ironshore Pharmaceuticals Inc.1$15

How this compares

$23,513 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$82,084
Medicare patients
251
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →